| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/01/2013 | US8546096 Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI |
| 10/01/2013 | US8546094 Ubiquitin ligase and use thereof |
| 10/01/2013 | US8546083 Molecular accessibility assay |
| 10/01/2013 | US8546082 Methods for identification of sepsis-causing bacteria |
| 10/01/2013 | US8546081 Methods and compositions for assaying a sample for an aggregant |
| 10/01/2013 | US8546080 Molecular dispensers |
| 10/01/2013 | US8546079 Reporter gene construct, assay kit and detection method |
| 10/01/2013 | US8546078 Materials and method for assaying for methylation of CpG islands associated with genes in the evaluation of cancer |
| 10/01/2013 | US8546077 Prostaglandin E2 modulation and uses thereof |
| 10/01/2013 | US8546076 Mutational profile in HIV-1 GAG cleavage site correlated with phenotypic drug resistance |
| 10/01/2013 | US8546075 Method of detecting hepatitis C virus |
| 10/01/2013 | US8546074 Sir2 activity |
| 10/01/2013 | US8546073 Method and apparatus for enhanced detection of toxic agents |
| 10/01/2013 | US8546072 Substrate for assaying β-glucan and/or endotoxin and assay method |
| 10/01/2013 | US8546071 High-throughput in vitro translation (cell-lysate based) assay for detecting quorum sensing signals |
| 10/01/2013 | US8545814 Non-invasive localization of a light-emitting conjugate in a mammal |
| 10/01/2013 | US8545693 Analyte measurment method and system |
| 10/01/2013 | CA2695473C Predictive marker for egfr inhibitor treatment |
| 10/01/2013 | CA2689741C Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 10/01/2013 | CA2678967C Rna targeting compounds and methods for making and using same |
| 10/01/2013 | CA2675103C Micro-array analysis system and method thereof |
| 10/01/2013 | CA2611091C Biosensor strips and methods of preparing same |
| 10/01/2013 | CA2603352C Molecular characterization with carbon nanotube control |
| 10/01/2013 | CA2598859C Transgenic animal as a model for fibrotic diseases |
| 10/01/2013 | CA2543586C A method for monitoring the presence of biofilm-forming microorganisms in paper industry |
| 10/01/2013 | CA2535770C Method for detecting cancer cells and monitoring cancer therapy |
| 10/01/2013 | CA2504694C Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 10/01/2013 | CA2495456C Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 10/01/2013 | CA2479835C An ephrin-b receptor protein involved in carcinoma |
| 10/01/2013 | CA2475680C Method for in vitro detection of cancers by highlighting allelic imbalances in insertion/deletion markers |
| 10/01/2013 | CA2467689C Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase |
| 10/01/2013 | CA2454873C Novel transformed cell, method for screening anti-aging agent, and anti-aging agent |
| 10/01/2013 | CA2453984C Resistance to powdery mildew infection and absence of necrosis in cucumber, cucumis sativus |
| 10/01/2013 | CA2436530C Environmentally regulated genes of streptococcus suis |
| 10/01/2013 | CA2433296C Focused acoustic ejection cell sorting system and method |
| 10/01/2013 | CA2408038C Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
| 10/01/2013 | CA2366520C Anti-bacterial vaccine compositions |
| 10/01/2013 | CA2211316C Method of designing alpha-amylase mutants with predetermined properties |
| 09/30/2013 | CA2772889A1 Real time multipoint assay for optimizing performance |
| 09/28/2013 | CA2773151A1 Cancer diagnostic kit to monitor the activity of protein kinase ck2, the methods and compositions thereof |
| 09/27/2013 | WO2012128898A1 Multisignal labeling reagents and processes and uses therefor |
| 09/27/2013 | CA2827754A1 Multisignal labeling reagents and processes and uses therefor |
| 09/26/2013 | WO2013142758A1 Compositions and methods for in vitro diagnostic tests including sulfonic acid |
| 09/26/2013 | WO2013142735A1 Targeting domain and related signal activated molecular delivery |
| 09/26/2013 | WO2013142545A1 Marker panel for detecting cancer |
| 09/26/2013 | WO2013142378A1 Fast diagnosis and personalized treatments for acne |
| 09/26/2013 | WO2013142364A1 Modified rnase h enzymes and their uses |
| 09/26/2013 | WO2013142348A1 Molecular markers for low palmitic acid content in sunflower (helianthus annus), and methods of using the same |
| 09/26/2013 | WO2013142347A1 Method and system for detection of microbial growth in a specimen container |
| 09/26/2013 | WO2013142341A1 A novel rapid and highly sensitive cell based system for the detection and characterization of hiv |
| 09/26/2013 | WO2013142286A1 Genetic alterations associated with autism and the autistic phenotype in the israeli population and methods of use thereof for the diagnosis and treatment of autism |
| 09/26/2013 | WO2013142003A1 Biologic machines for the detection of biomolecules |
| 09/26/2013 | WO2013141842A2 Genome-based drug management systems |
| 09/26/2013 | WO2013141833A2 Genetic based health management apparatus and methods |
| 09/26/2013 | WO2013141816A1 A method of diagnosing and/or treating corneal fibrosis |
| 09/26/2013 | WO2013141716A1 Biomarkers |
| 09/26/2013 | WO2013141705A2 Means and methods for response prediction of hepatitis b treatment |
| 09/26/2013 | WO2013141451A1 Oil-containing microorganism harvesting and bio-oil production method using nanoclay |
| 09/26/2013 | WO2013141383A1 Gene encoding of enzyme for reducing position 24 of steroid skeleton and plant having reduced expression of same gene |
| 09/26/2013 | WO2013141332A1 Method for identification and detection of mutant gene using intercalator |
| 09/26/2013 | WO2013141331A1 Method for detecting dna having microsatellite region |
| 09/26/2013 | WO2013141291A1 Device for target analysis of streptavidin, and analysis method |
| 09/26/2013 | WO2013141266A1 Method for detecting novel ret fused body |
| 09/26/2013 | WO2013140927A1 Method for screening therapeutic and/or prophylactic agents for alzheimer's disease |
| 09/26/2013 | WO2013140890A1 Method for detecting target nucleic acid molecule |
| 09/26/2013 | WO2013140681A1 Device for target analysis, and analysis method |
| 09/26/2013 | WO2013140629A1 Atp or amp analysis device and analysis method |
| 09/26/2013 | WO2013140468A1 Method for identifying olfactory receptor contained in one olfactory cell |
| 09/26/2013 | WO2013140339A1 Positive control for pcr |
| 09/26/2013 | WO2013140161A1 Method for determining prognosis of prostate cancer in a subject |
| 09/26/2013 | WO2013140107A1 Polymerase chain reaction detection system using oligonucleotides comprising a phosphorothioate group |
| 09/26/2013 | WO2013139860A1 Methods for assessing rna quality |
| 09/26/2013 | WO2013139829A1 Device for detection of analytes in affinity bioassays |
| 09/26/2013 | WO2013139711A1 Methods for determining the tropism and receptor usage of a virus, in particular hiv, in body samples taken from the circulation |
| 09/26/2013 | WO2013139700A1 Memory genes |
| 09/26/2013 | WO2013139554A1 Gram staining method with improved decolorization of the crystal violet-iodine complex from gram negative bacteria |
| 09/26/2013 | WO2013139479A1 New diagnostic markers of specific chronic myelomonocytic leukemia (cmml) |
| 09/26/2013 | WO2013139478A1 Profiling oligosaccharides associated with biological activities of heparin or heparin derivatives |
| 09/26/2013 | WO2013138937A1 A nucleic acid detection method comprising target specific indexing probes (tsip) comprising a releasable segment to be detected via fluorescence when bound to a capture probe |
| 09/26/2013 | WO2013096777A9 Integrated compound discovery systems and methods |
| 09/26/2013 | WO2012154994A3 A novel adenovirus isolated from titi monkeys |
| 09/26/2013 | WO2012135620A3 Molecular gram stain |
| 09/26/2013 | WO2012078365A3 Biomarkers for prediction of breast cancer |
| 09/26/2013 | WO2009152353A3 Reversible nucleosides and nucleotides terminators and their use in dna sequencing |
| 09/26/2013 | US20130254944 Herbicide Tolerant Soybeans and Methods of Use |
| 09/26/2013 | US20130254927 Molecular markers for low palmitic acid content in sunflower (helianthus annus), and methods of using the same |
| 09/26/2013 | US20130253369 System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| 09/26/2013 | US20130253046 Methods of treating cancer comprising targeting nqo1 |
| 09/26/2013 | US20130253037 Aurora a kinase effectors |
| 09/26/2013 | US20130253035 Camkk-beta as a target for treating cancer |
| 09/26/2013 | US20130253034 2'-Arabino-Fluorooligonucleotide N3'-->P5' Phosphoramidates: Their Synthesis and Use |
| 09/26/2013 | US20130253007 Compounds That Modulate Oxidative Stress |
| 09/26/2013 | US20130252983 Activating phosphorylation site on glutaminase c |
| 09/26/2013 | US20130252950 Targeting mtor substrates in treating proliferative diseases |
| 09/26/2013 | US20130252906 Compounds and methods for treating or preventing disease conditions associated with alpha-1-antitrypsin |
| 09/26/2013 | US20130252852 Oligonucleotides Related to Lipid Membrane Attachment |
| 09/26/2013 | US20130252845 Method for screening skin aging-related genes and materials for preventing skin aging |
| 09/26/2013 | US20130252844 Sugarcane-stalk-sugar-content-related marker and the use thereof |
| 09/26/2013 | US20130252842 Methine-Substituted Cyanine Dye Compounds |
| 09/26/2013 | US20130252840 Liquid tissue preparation from histopathologically processed biologically samples, tissues and cells |